{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:19:06Z","timestamp":1784675946422,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T00:00:00Z","timestamp":1595635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T00:00:00Z","timestamp":1595635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Locally recurrent rectal cancer (LRRC) after surgery or external beam radiotherapy (EBRT) is a serious challenge for which no standard treatment is defined. In the present study, we investigated the feasibility of computed tomography (CT)-guided radioactive <jats:sup>125<\/jats:sup>I seed (RIS) implantation assisted with three-dimensional printing non-coplanar template (3D-PNCT) in LRRC patients who previously received surgery or EBRT.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Sixty-six patients with LRRC treated by CT-guided RIS implantation in our institute from December 2015 to May 2019 were included. The treatment procedure included: preoperative CT localization, planning design, the printing of 3D individualized template, CT-guided RIS implantation assisted with 3D-PNCT, and postoperative dose evaluation. Therapeutic outcomes including local control (LC) and overall survival (OS) were retrospectively evaluated, as well as side effects.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>All the patients had previously received surgery or EBRT. The median follow-up time was 12.2 (range, 2.5\u201335.9) months. The median radioactive activity of a single RIS was 0.6 (range, 0.43\u20130.72) mCi. The median number of RIS was 60, ranging from 10 to 175. The dosimetric parameters included D90 (140.7\u2009\u00b1\u200933.1) Gy, D100 (90.3\u2009\u00b1\u2009138.6) Gy, and V100 (91.0\u2009\u00b1\u200913.3) %. Pain relief was achieved in 85.1% (40\/47) of patients. Besides, 9.1% (6\/66) of patients had severe side effects (\u2265grade 3), including perianal skin ulcer in 1 case, fistula, radiation proctitis, and intestinal obstruction each in two cases. Median OS time was 14.7 (95% confidence interval (CI): 13.0\u201316.3) months, and median LC time was 12.2 (95% CI: 9.1\u201315.2) months. Univariate analysis revealed that when D90\u2009&gt;\u2009130\u2009Gy or D100\u2009&gt;\u200955\u2009Gy or V100\u2009&gt;\u200990%, the LC time was remarkably prolonged. However, none of the parameters significantly affected OS.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>CT-guided RIS implantation assisted with 3D-PNCT is an effective and safe salvage treatment strategy for patients with LRRC after EBRT or surgery. D90, D100, and V100 can be used as prognostic predictors.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Trial registration<\/jats:title>\n<jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03890926?term=NCT03890926&amp;draw=2&amp;rank=1\">NCT03890926<\/jats:ext-link>.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13014-020-01607-2","type":"journal-article","created":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T09:03:42Z","timestamp":1595667822000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The efficacy and dosimetry analysis of CT-guided 125I seed implantation assisted with 3D-printing non-co-planar template in locally recurrent rectal\u00a0cancer"],"prefix":"10.1186","volume":"15","author":[{"given":"Lu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuxin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,25]]},"reference":[{"issue":"9","key":"1607_CR1","doi-asserted-by":"publisher","first-page":"5105","DOI":"10.21873\/anticanres.13705","volume":"39","author":"O Iskander","year":"2019","unstructured":"Iskander O, Courtot L, Tabchouri N, et al. Complete pathological response following Radiochemotherapy for locally advanced rectal Cancer: short and long-term outcome. Anticancer Res. 2019;39(9):5105\u201313.","journal-title":"Anticancer Res"},{"issue":"6","key":"1607_CR2","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1245\/s10434-014-4219-z","volume":"22","author":"D Habermehl","year":"2015","unstructured":"Habermehl D, Wagner M, Ellerbrock M, et al. Reirradiation using carbon ions in patients with locally recurrent rectal cancer at HIT: first results. Ann Surg Oncol. 2015;22(6):2068\u201374.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"1607_CR3","first-page":"502","volume":"237","author":"D Hahnloser","year":"2003","unstructured":"Hahnloser D, Nelson H, Gunderson LL, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg. 2003;237(4):502\u20138.","journal-title":"Ann Surg"},{"issue":"6","key":"1607_CR4","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00384-015-2182-1","volume":"30","author":"M Rasanen","year":"2015","unstructured":"Rasanen M, Carpelan-Holmstrom M, Mustonen H, Renkonen-Sinisalo L, Lepisto A. Pattern of rectal cancer recurrence after curative surgery. Int J Color Dis. 2015;30(6):775\u201385.","journal-title":"Int J Color Dis"},{"issue":"33","key":"1607_CR5","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.3748\/wjg.v25.i33.4850","volume":"25","author":"G Feeney","year":"2019","unstructured":"Feeney G, Sehgal R, Sheehan M, et al. Neoadjuvant radiotherapy for rectal cancer management. World J Gastroenterol. 2019;25(33):4850\u201369.","journal-title":"World J Gastroenterol"},{"key":"1607_CR6","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S0959-8049(02)00052-7","volume":"38","author":"MEJ Pijl","year":"2002","unstructured":"Pijl MEJ, Chaoui AS, Wahl RL, Oostayen JA. Radiology of colorectal cancer. Eur J Cancer. 2002;38:887\u201398.","journal-title":"Eur J Cancer"},{"issue":"2","key":"1607_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s12032-009-9227-7","volume":"27","author":"JJ Wang","year":"2009","unstructured":"Wang JJ, Yuan HS, Li JN, Jiang YL, Tian SQ, Yang RJ. CT-guided radioactive seed implantation for recurrent rectal carcinoma after multiple therapy. Med Oncol. 2009;27(2):421\u20139.","journal-title":"Med Oncol"},{"key":"1607_CR8","unstructured":"National Comprehensive Cancer Networks (NCCN). The NCCN rectal cancer clinical practice guidelines in oncology (version 2 2020). 2020."},{"issue":"2","key":"1607_CR9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347.","journal-title":"Eur J Cancer"},{"key":"1607_CR10","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S0140-6736(74)90884-8","volume":"2","author":"EC Huskisson","year":"1974","unstructured":"Huskisson EC. Measurement of pain. Lancet. 1974;2:1127\u201331.","journal-title":"Lancet"},{"issue":"5","key":"1607_CR11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"JD Cox","year":"1995","unstructured":"Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31(5):1341\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1607_CR12","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1046\/j.0007-1323.2001.01811.x","volume":"88","author":"K Yamada","year":"2001","unstructured":"Yamada K, Ishizawa T, Niwa K, Chuman Y, Akiba S, Aikou T. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg. 2001;88:988\u201393.","journal-title":"Br J Surg"},{"issue":"7","key":"1607_CR13","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1245\/s10434-008-9896-z","volume":"15","author":"RC Dresen","year":"2008","unstructured":"Dresen RC, Gosens MJ, Martijn H, et al. Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol. 2008;15(7):1937\u201347.","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"1607_CR14","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1007\/BF02235044","volume":"42","author":"HJ Wanebo","year":"1999","unstructured":"Wanebo HJ, Antoniuk P, Koness JR, et al. Pelvic resection of recurrent rectal cancer. Dis Colon Rectum. 1999;42(11):1438\u201348.","journal-title":"Dis Colon Rectum"},{"issue":"23","key":"1607_CR15","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.3748\/wjg.v23.i23.4170","volume":"23","author":"DJK Lee","year":"2017","unstructured":"Lee DJK, Sagar PM, Sadadcharam G, Tan KY. Advances in surgical management for locally recurrent rectal cancer: how far have we come? World J Gastroenterol. 2017;23(23):4170\u201380.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1607_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/(SICI)1096-9098(200001)73:1<47::AID-JSO12>3.0.CO;2-M","volume":"73","author":"WJ Temple","year":"2000","unstructured":"Temple WJ, Saettler EB. Locally recurrent rectal cancer: role of composite resection of extensive pelvic tumors with strategies for minimizing risk of recurrence. J Surg Oncol. 2000;73(1):47\u201358.","journal-title":"J Surg Oncol"},{"issue":"2","key":"1607_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.radonc.2014.11.021","volume":"113","author":"MG Guren","year":"2014","unstructured":"Guren MG, Undseth C, Rekstad BL, et al. Reirradiation of locally recurrent rectal cancer: a systematic review. Radiother Oncol. 2014;113(2):151\u20137.","journal-title":"Radiother Oncol"},{"key":"1607_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.radonc.2019.05.021","volume":"140","author":"J Lee","year":"2019","unstructured":"Lee J, Kim CY, Koom WS, et al. Practical effectiveness of re-irradiation with or without surgery for locoregional recurrence of rectal cancer: a meta-analysis and systematic review. Radiother Oncol. 2019;140:10\u20139.","journal-title":"Radiother Oncol"},{"key":"1607_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13014-016-0752-1","volume":"12","author":"MG Haddock","year":"2017","unstructured":"Haddock MG. Intraoperative radiation therapy for colon and rectal cancers: a clinical review. Radiat Oncol. 2017;12:11.","journal-title":"Radiat Oncol"},{"issue":"8","key":"1607_CR20","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00384-015-2270-2","volume":"30","author":"WJ Alberda","year":"2015","unstructured":"Alberda WJ, Haberkorn BC, Morshuis WG, et al. Response to chemotherapy in patients with recurrent rectal cancer in previously irradiated area. Int J Color Dis. 2015;30(8):1075\u201380.","journal-title":"Int J Color Dis"},{"key":"1607_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/978-1-61779-015-7_16","volume-title":"Intraoperative irradiation","author":"MG Haddock","year":"2011","unstructured":"Haddock MG, Nelson H, Valentini V. Recurrent colorectal Cancer. In: Gunderson LL, Willett CG, Calvo F, editors. Intraoperative irradiation. New York: Humana Press; 2011. p. 323\u201351."},{"key":"1607_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0360-3016(95)02048-9","volume":"34","author":"E Bussieres","year":"1996","unstructured":"Bussieres E, Gilly FN, Rouanet P. Recurrences of rectal Cancer: results of a multimodal approach with intraoperative radiation therapy. Int J Radiat Oncol Biol Phys. 1996;34:49\u201356.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1607_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijrobp.2009.10.046","volume":"79","author":"MG Haddock","year":"2011","unstructured":"Haddock MG, Miller RC, Nelson H, et al. Combined modality therapy including intraoperative electron irradiation for locally recurrent colorectal cancer. Int J Radiat Oncol Biol Phys. 2011;79(1):143\u201350.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1607_CR24","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/1748-717X-6-138","volume":"6","author":"ZM Wang","year":"2011","unstructured":"Wang ZM, Lu J, Liu L, et al. Clinical application of CT-guided 125I seed interstitial implantation for local recurrent rectal carcinoma. Radiat Oncol. 2011;6:138.","journal-title":"Radiat Oncol"},{"key":"1607_CR25","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/BF02055163","volume":"40","author":"RN Goes","year":"1997","unstructured":"Goes RN, Beart RW Jr, Simons AJ, et al. Use of brachytherapy in management of locally recurrent rectal cancer. Dis Colon Rectum. 1997;40:1177\u20139.","journal-title":"Dis Colon Rectum"},{"key":"1607_CR26","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0360-3016(98)00269-7","volume":"42","author":"R Martinez-Monge","year":"1998","unstructured":"Martinez-Monge R, Naq S, Martin EW. 125Iodine brachytherapy for colorectal adenocarcinoma recurrent in the pelvis and paraortics. Int J Radiat Oncal Biol Phys. 1998;42:545\u201350.","journal-title":"Int J Radiat Oncal Biol Phys"},{"issue":"4","key":"1607_CR27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.brachy.2012.03.006","volume":"12","author":"M Keyes","year":"2013","unstructured":"Keyes M, Morris WJ, Spadinger I, et al. Radiation oncology and medical physicists quality assurance in British Columbia Cancer Agency provincial prostate brachytherapy program. Brachytherapy. 2013;12(4):343\u201355.","journal-title":"Brachytherapy"},{"issue":"5","key":"1607_CR28","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.ijrobp.2010.07.1975","volume":"81","author":"A Zapatero","year":"2011","unstructured":"Zapatero A, Garcia-Vicente F, Martin de Vidales C, et al. Long-term results after high-dose radiotherapy and adjuvant hormones in prostate cancer: how curable is high-risk disease? Int J Radiat Oncol Biol Phys. 2011;81(5):1279\u201385.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-020-01607-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-020-01607-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-020-01607-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T23:04:28Z","timestamp":1627167868000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-020-01607-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,25]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1607"],"URL":"https:\/\/doi.org\/10.1186\/s13014-020-01607-2","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,25]]},"assertion":[{"value":"20 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Ethics Committee of Peking University Third Hospital [IRB00006761].","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"179"}}